Stockscreener 앱 받기
16.80
4.51%
0.725
전일 마감가:
$16.08
열려 있는:
$16.17
하루 거래량:
23.01M
Relative Volume:
0.88
시가총액:
$32.26B
수익:
$15.14B
순이익/손실:
$1.42B
주가수익비율:
22.83
EPS:
0.7361
순현금흐름:
$1.63B
1주 성능:
+6.83%
1개월 성능:
-10.94%
6개월 성능:
-22.84%
1년 성능:
-21.95%
1일 변동 폭
$16.06
$16.84
1주일 범위
$15.60
$16.84
52주 변동 폭
$15.47
$25.17
Kenvue Inc Stock (KVUE) Company Profile
명칭
Kenvue Inc
전화
908-874-1200
주소
1 KENVUE WAY, SUMMIT
KVUE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
16.81 | 30.86B | 15.14B | 1.42B | 1.63B | 0.7361 |
|
PG
Procter Gamble Co
|
150.48 | 352.69B | 84.28B | 16.07B | 14.05B | 6.5067 |
|
UL
Unilever Plc Adr
|
58.94 | 143.78B | 64.99B | 6.71B | 6.53B | 2.4355 |
|
CL
Colgate Palmolive Co
|
78.28 | 63.04B | 20.00B | 3.05B | 3.37B | 3.5578 |
|
KMB
Kimberly Clark Corp
|
119.69 | 39.69B | 18.88B | 2.38B | 2.10B | 7.2549 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-26 | 업그레이드 | Rothschild & Co Redburn | Neutral → Buy |
| 2025-04-10 | 개시 | Redburn Atlantic | Neutral |
| 2025-03-24 | 개시 | Evercore ISI | In-line |
| 2025-01-06 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-12 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2024-09-24 | 개시 | Jefferies | Buy |
| 2024-09-24 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-05-28 | 재개 | Citigroup | Neutral |
| 2024-04-11 | 개시 | Bernstein | Underperform |
| 2024-04-03 | 개시 | William Blair | Mkt Perform |
| 2024-03-01 | 재개 | Goldman | Neutral |
| 2023-11-17 | 개시 | Piper Sandler | Neutral |
| 2023-09-11 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2023-09-07 | 개시 | Canaccord Genuity | Buy |
| 2023-09-06 | 개시 | Argus | Hold |
| 2023-08-24 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-07-25 | 개시 | Edward Jones | Buy |
| 2023-06-01 | 개시 | HSBC Securities | Hold |
| 2023-05-30 | 개시 | BofA Securities | Buy |
| 2023-05-30 | 개시 | Citigroup | Neutral |
| 2023-05-30 | 개시 | Deutsche Bank | Hold |
| 2023-05-30 | 개시 | Exane BNP Paribas | Neutral |
| 2023-05-30 | 개시 | Goldman | Neutral |
| 2023-05-30 | 개시 | JP Morgan | Overweight |
| 2023-05-30 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 개시 | UBS | Neutral |
모두보기
Kenvue Inc 주식(KVUE)의 최신 뉴스
November 28th Options Now Available For Kenvue (KVUE) - Nasdaq
Is Kenvue Inc. stock a buy in volatile marketsEntry Point & Daily Oversold Bounce Ideas - newser.com
Chart based analysis of Kenvue Inc. trends2025 Valuation Update & Precise Buy Zone Tips - newser.com
Is Kenvue Inc. (J4D) stock a buy for dividend portfoliosStock Surge & Weekly High Return Stock Opportunities - newser.com
Kenvue Inc. $KVUE Shares Sold by Belpointe Asset Management LLC - MarketBeat
Comparing Kenvue Inc. in custom built stock radarsDay Trade & Free Verified High Yield Trade Plans - newser.com
Is Kenvue Inc. a candidate for recovery play2025 Price Targets & Weekly High Return Opportunities - newser.com
QRG Capital Management Inc. Buys 29,813 Shares of Kenvue Inc. $KVUE - MarketBeat
Donald Trump’s Tylenol Warning Makes Kenvue Stock (KVUE) an Opportunity in Disguise - TipRanks
Kenvue (KVUE): Exploring Valuation After Recent Share Price Weakness - Yahoo Finance
Kenvue’s SWOT analysis: stock faces Tylenol headwinds amid strategic shift - Investing.com
Kenvue’s SWOT analysis: stock faces Tylenol headwinds amid strategic shift By Investing.com - Investing.com UK
Kenvue (NYSE:KVUE) Price Target Lowered to $21.00 at Bank of America - MarketBeat
Moderately bullish activity in Kenvue Inc with shares down 0.59% - TipRanks
Kenvue Becomes Oversold - Nasdaq
How the Narrative Around Kenvue Is Shifting Amid Legal and Regulatory Headwinds - Yahoo Finance
UBS Adjusts Kenvue Price Target to $17 From $23, Maintains Neutral Rating - MarketScreener
Kenvue price target lowered to $17 from $23 at UBS - TipRanks
These Were the 5 Worst-Performing Stocks in the S&P 500 in September 2025 -- and One's Decline Can Be Tied to President Trump - The Motley Fool
Citigroup Adjusts Price Target on Kenvue to $17 From $20, Maintains Neutral Rating - MarketScreener
WESPAC Advisors LLC Invests $544,000 in Kenvue Inc. $KVUE - MarketBeat
Near 52-Week Low, Should You Buy Kenvue Stock? - The Globe and Mail
KLP Kapitalforvaltning AS Has $22.45 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Simplicity Wealth LLC Purchases Shares of 24,210 Kenvue Inc. $KVUE - MarketBeat
Did Trump’s Tylenol Pregnancy Warning Just Shift Kenvue's (KVUE) Brand Risk Profile? - simplywall.st
Kenvue’s (KVUE) Long-Term Value Creation and its Place in NYSE Dividend Stocks - MSN
Bullish flow in Kenvue Inc with shares up 3.22% - TipRanks
Options Corner: Despite Political Woes, Kenvue Can Still Make Tylenol Great Again - Sahm
Is Kenvue Inc. stock a buy before new product rolloutJuly 2025 Highlights & Low Risk Entry Point Tips - newser.com
Visual trend scoring systems applied to Kenvue Inc.Stop Loss & AI Driven Price Forecasts - newser.com
Kenvue Inc. $KVUE Shares Sold by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Why Is Kenvue Stock Falling, and Is It a Buying Opportunity? - The Motley Fool
What insider purchases suggest about Kenvue Inc. stockMarket Performance Summary & AI Powered Market Trend Analysis - newser.com
How strong is Kenvue Inc. stock earnings growth2025 Trading Volume Trends & AI Driven Stock Price Forecasts - newser.com
Why retail traders accumulate Kenvue Inc. stockJuly 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - newser.com
Will Kenvue Inc. stock outperform benchmarksTrade Risk Report & AI Enhanced Trade Execution Alerts - newser.com
Why analysts raise outlook for Kenvue Inc. (J4D) stockEarnings Overview Report & Accurate Technical Buy Alerts - newser.com
Why millennials buy Kenvue Inc. stockMarket Trend Review & Reliable Entry Point Alerts - newser.com
Litigation risks for Kenvue: focus shifts to U.S. appeals court - Investing.com
Is Kenvue Inc. stock near bottom after decline2025 Fundamental Recap & Real-Time Market Sentiment Alerts - newser.com
Assessing Kenvue (KVUE) Valuation: Is the Stock Priced for a Potential Turnaround? - simplywall.st
Market Movers: Metsera and Apple surge, Kenvue falters on Tylenol troubles - MSN
Truist Financial Corp Has $16.46 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Moody’s changes Kenvue outlook to negative amid operational challenges - Investing.com
Is Kenvue Inc. stock poised for growthTrend Reversal & AI Enhanced Execution Alerts - newser.com
Lawmakers dump Tylenol stock before autism controversy - Vermont Daily Chronicle
Goldman Sachs Sticks To Its Hold Rating For Kenvue, Inc. (KVUE) - Barchart.com
How Kenvue Inc. (J4D) stock performs in easing cycles2025 Short Interest & Real-Time Volume Triggers - newser.com
Barclays Lowers PT on Kenvue (KVUE) to $17 From $20, Keeps an Equal Weight Rating - Yahoo Finance
Is Kenvue Inc. stock among top earnings playsTrade Signal Summary & Consistent Profit Trade Alerts - newser.com
Is There an Opportunity in Kenvue After Recent 24% Share Price Drop? - simplywall.st
Kenvue Inc (KVUE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.04%
1.54%
자본화:
|
볼륨(24시간):